Related Experiment Video
Updated: Sep 4, 2026
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Salmonella gastroenteritis in children: six-year experience in İstanbul, Turkey
Ayşe Karaaslan1, Ceren Çetin2, Mehmet Tolga Köle3
1Department of Pediatric Infectious Diseases, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey. akaraaslan78@gmail.com.
Insights
Salmonella gastroenteritis in children often presents with diarrhea and fever. Hospitalized patients typically show more severe symptoms and higher C-reactive protein levels, warranting prompt medical attention and potential antibiotic therapy.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Salmonella gastroenteritis is a common cause of pediatric illness.
- Understanding its clinical spectrum and treatment is crucial for effective management.
Purpose of the Study:
- To analyze the demographic and clinical features of Salmonella gastroenteritis in children.
- To evaluate treatment outcomes and identify factors associated with hospitalization.
Main Methods:
- Retrospective review of medical records for pediatric patients (1 month to 18 years).
- Data collected from May 2015 to December 2021.
- Analysis of clinical symptoms, Salmonella serogroups, antimicrobial susceptibility, and patient outcomes.
Main Results:
- 172 children diagnosed with Salmonella gastroenteritis were studied.
- Common symptoms included diarrhea (96.5%), fever (65.7%), and abdominal pain (42.4%).
- Hospitalized patients exhibited more frequent fever, vomiting, and higher C-reactive protein levels (p<0.005).
Conclusions:
- Salmonella should be suspected in pediatric cases of abdominal pain, fever, and bloody diarrhea.
- Severe cases require hospitalization and consideration of antibiotic therapy based on clinical indicators.
Introduction:
The aim of this study was to evaluate the demographic and clinical characteristics and treatment outcomes of children with Salmonella gastroenteritis.
Methodology:
We retrospectively reviewed the medical records of pediatric patients aged between 1 month and 18 years with the diagnosis of Salmonella gastroenteritis between May 2015 and December 2021.
Results:
A total of 172 children diagnosed with Salmonella gastroenteritis, including 113 outpatients and 59 hospitalized children, were included in this study. There were 95 (55.2%) males and 77 (44.8%) females with a median age of 59.5 months (interquartile range [IQR]: 33.5-96 months, min-max: 1-205 months). The most common clinical symptoms were diarrhea (n = 166, 96.5%), fever (n = 113, 65.7%) and abdominal pain (n = 73, 42.4%). Bloody diarrhea was seen in 19.2% of patients. Fifty (29.1%) of the Salmonella species could not be typed. Serogroup D (n = 106, 61.6%) was the predominant serogroup isolated from stool cultures, followed by serogroup B (n = 16, 9.3%). 62.2% of the isolates were susceptible to ampicillin, 97.7% to ciprofloxacin, 98.8% to trimethoprim-sulfamethoxazole, and 98.8% to ceftriaxone. Fever, vomiting, and underlying disease occurred more frequently in hospitalized patients than in outpatients (p: 0.005, p: 0.000, p: 0.000, respectively). C-reactive protein value was found to be higher in hospitalized patients (p: 0.000).
Conclusions:
Salmonella should be considered as a causative agent in pediatric patients with abdominal pain, fever, and bloody-mucous diarrhea, and patients with severe clinical conditions should be hospitalized and antibiotic therapy initiated if indicated.
Related Concept Videos
01:23Investigation of Disease Outbreaks
01:18Bacterial Gastroenteritis
01:17Poliomyelitis
01:12Giardiasis